Essilorluxottica (OTC) (ESLOY) announced an update on their ongoing clinical study. Essilorluxottica is currently conducting a clinical study titled A Monocentre, Randomized, Contralateral Trial to ...
Please provide your email address to receive an email when new articles are posted on . Combining orthokeratology lenses with atropine eye drops may lead to better myopia control but also increase ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The relationship between diet and nearsightedness ...
Background To evaluate the efficacy and safety of repeated low-level red-light (RLRL) therapy for controlling myopia ...
Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050. Ophthalmologists are gravely concerned that these ...
David Berntsen, Golden-Golden Professor of Optometry and chair of Clinical Sciences at the University of Houston College of Optometry, is reporting that his team’s method to slow myopia not only works ...
Essilorluxottica is currently conducting a clinical study titled A Monocentre, Randomized, Contralateral Trial to Study the Effect of Temporal Changes in Ocular Biometry of Two Myopia Control Lenses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results